Acute Lymphoblastic Leukemia Immunotherapy Treatment: Now, Next, and Beyond

SIMPLE SUMMARY: The recent emergence of targeted therapies, including antibody–drug conjugates, bispecific antibodies, and CD19 chimeric antigen receptor (CAR) T cell therapy, revolutionized B-lineage acute lymphoblastic leukemia (B-ALL) management, allowing certain optimism, at least for adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Aureli, Anna, Marziani, Beatrice, Venditti, Adriano, Sconocchia, Tommaso, Sconocchia, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340788/
https://www.ncbi.nlm.nih.gov/pubmed/37444456
http://dx.doi.org/10.3390/cancers15133346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340788/
https://www.ncbi.nlm.nih.gov/pubmed/37444456
http://dx.doi.org/10.3390/cancers15133346

Ejemplares similares